Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype.
Open Access
- 1 July 1991
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 174 (1) , 93-102
- https://doi.org/10.1084/jem.174.1.93
Abstract
Membrane cofactor protein (MCP) is a complement regulatory protein that is expressed on human cells and cell lines as two relatively broad species with Mr of 58,000-68,000 and 48,000-56,000. The structure of a previously reported cDNA clone indicated that MCP was a type 1 membrane glycoprotein and a member of the regulators of complement activation gene/protein cluster. However, it did not provide an explanation for the unusual phenotypic pattern of MCP. Therefore, in parallel with an analysis of the gene, additional cDNAs were cloned and characterized. Six different MCP cDNA classes were identified. All encode the same 5' untranslated signal peptide, four SCRs, transmembrane domain, and basic amino acid anchor. However, they differ in the length and composition of an extracellular serine/threonine/proline (STP)-rich area, a site of heavy O-glycosylation, and cytoplasmic tail. Analysis of the MCP gene demonstrated that the variation in cDNA structure was a result of alternative splicing. Peripheral blood cells and cell lines predominantly expressed four of the six isoforms. These varied by the presence or absence of an STP-rich segment of 15 amino acids (STPB) and by the use of one of two cytoplasmic domains. Analysis by polymerase chain reaction, Northern blots, and transfection indicated that the predominance of MCP cDNA isoforms with STPB correlated with the high molecular weight protein phenotype, while the predominance of isoforms without STPB correlated with the lower molecular weight phenotype. The expression in a single cell of four distinct protein species with variable STP-rich regions and cytoplasmic tails represents an interesting example of the use of alternative splicing to provide variability in a mammalian protein.Keywords
This publication has 38 references indexed in Scilit:
- Membrane cofactor protein of the complement system. A HindIII restriction fragment length polymorphism that correlates with the expression polymorphism.The Journal of Immunology, 1991
- Functional properties of membrane cofactor protein of complementBiochemical Journal, 1989
- Effects of O-Linked Glycosylation on the Cell Surface Expression and Stability of Decay-accelerating Factor, a Glycophospholipid-anchored Membrane ProteinJournal of Biological Chemistry, 1989
- Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.Journal of Clinical Investigation, 1989
- Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytesEuropean Journal of Immunology, 1988
- Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.The Journal of Experimental Medicine, 1988
- Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.Proceedings of the National Academy of Sciences, 1987
- Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteinsNature, 1987
- Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody.The Journal of Immunology, 1986
- Identification of a third component of complement-binding glycoprotein of human platelets.Journal of Clinical Investigation, 1986